Community-acquired pneumonia in children

Paediatrics and Child Health

Volumn 8, Issue 10, 2003, Pages 616-619

  Dele Davies, H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Childhood; Community acquired; Diagnosis; Pneumonia

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLOXACILLIN; ERYTHROMYCIN; MACROLIDE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASPLENIA; BACTERIAL PNEUMONIA; CHILD; CHILDHOOD DISEASE; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; HAEMOPHILUS INFLUENZAE; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; INFANT; INTENSIVE CARE UNIT; MYCOPLASMA PNEUMONIA; OUTPATIENT CARE; PENICILLIN RESISTANCE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; RESPIRATORY DISTRESS; RESPIRATORY TRACT INFECTION; SICKLE CELL ANEMIA; SIDE EFFECT; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; VACCINATION;

EID: 0347764507     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/8.10.616     Document Type: Article

References (42)

1. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 2000;31:347-82.
2. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21:810-5.
3. Health Canada, National Advisory Committee on Immunization. Statement on recommended use of pneumococcal conjugate vaccine. CCDR 2002;28:1-32.
4. Adler-Shohet F, Lieberman JM. Bacterial pneumonia in children. Sem Pediatr Infect Dis 1998;9:191-8.
5. Harrison HR, English MG, Lee CK, Alexander ER. Chlamydia trachomatis infant pneumonitis: Comparison with matched controls and other infant pneumonitis. N Engl J Med 1978;298:702-8.
6. Beem MO, Saxon EM. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N Engl J Med 1977;296:306-10.
7. Tipple MA, Beem MO, Saxon EM. Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age. Pediatrics 1979;63:192-7.
8. Alexander ER, Foy HM, Kenny GE, et al. Pneumonia due to Mycoplasma pneumoniae. N Engl J Med 1966;275:131-6.
9. Foy HM, Cooney MK, Maletzky AJ, Grayston JT. Incidence and etiology of penumonia, croup and bronchiolitis in preschool children belonging to a prepaid medical group over a four-year period. Am J Epidemiol 1973;97:80-92.
10. Murphy TF, Henderson FW, Clyde WA Jr, Collier AM, Denny FW. Pneumonia: An eleven-year study in a pediatric practice. Am J Epidemiol 1981;113:12-21.
11. Denny FW, Clyde WA. Acute lower respiratory tract infections in nonhospitalized children. J Pediatr 1986;108:635-46.
12. Henrickson KJ. Viral pneumonia in children. Sem Pediatr Infect Dis 1998;9:217-33.
13. Turner RB, Lande AE, Chase P, et al. Pneumonia in pediatric outpatients: Cause and clinical manifestations. J Pediatr 1987;111:194-200.
14. Heiskanen-Kosma T, Korppi M, Jokinen C, et al. Etiology of childhood pneumonia: Serologic results of a prospective, population based study. Pediatr Infect Dis J 1998;17:986-91.
15. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-95.
16. Kaplan SL, Mason EO Jr, Wald E, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 2002;21:141-7.
17. Scheifele D, Halperin S, Pelletier L, et al. Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998. Can J Infect Dis 2001;12:241-6.
18. World Health Organization, Division of Child Health and Development. Integrated management of childhood illness. Geneva: World Health Organization, 1997.
19. Palafox M, Guiscafre H, Reyes H, Muñoz O, Martínez H. Diagnostic value of tachypnoea in pneumonia defined radiologically. Arch Dis Child 2000;82:41-5.
20. Taylor JA, Del Beccaro M, Done S, Winters W. Establishing clinically relevant standards for tachypnea in febrile children younger than 2 years. Arch Pediatr Adolesc Med 1995;149:283-7.
21. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 1990;69:307-16.
22. Brady MT. Nosocomial legionnaire's disease in a children's hospital. J Pediatr 1989;115:46-50.
23. Starke JR, Correa AG. Management of mycobacterial infection and disease in children. Pediatr Infect Dis J 1995;14:455-70.
24. Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics 2003;112:e261.
25. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
26. Centers for Disease Control and Prevention. Updated Interim U.S. Case Definition for Severe Acute Respiratory Syndrome (SARS) 〈 www.cdc.gov/ncidod/sars/casedefinition.htm〉 (Version current at November 12, 2003).
27. Redd SC, Patrick E, Vreuls R, Metsing M, Moteetee M. Comparison of the clinical and radiographic diagnosis of paediatric pneumonia. Trans Royal Soc Trop Med Hyg 1994;88:307-10.
28. Davies HO, Wang EEL, Manson D, Babyn P, Schuckett B. The chest radiograph in diagnosing pneumonia in young infants. Pediatr Infect Dis J 1996;15:600-4.
29. Wald E. Recurrent pneumonia in children. Adv Pediatr Infect Dis 1990;5:183-203.
30. Toikka P, Irjala K, Juven T, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19:598-602.
31. Kogan R, Martýnez M, Rubilar L, Paya E, et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Pediatr Pulmonol 2003;35:91-8.
32. Beem MO, Saxon E, Tipple MA. Treatment of chlamydial pneumonia of infancy. Pediatrics 1979;63:198-203.
33. Chartrand SA, McCracken GH. Staphylococcal pneumonia in infants and children. Pediatr Infect Dis 1982;1:19-23.
34. Asmar BI, Slovis TL, Reed JO, Dajani AS. Hemophilus influenzae type b pneumonia in 43 children. J Pediatr 1978;93:389-93.
35. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
36. Bradley JS, Kaplan SL, Klugman KP, Leggiardo RJ. Consensus: Management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J 1995;14:1037-41.
37. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995;14:471-7.
38. Harris JS, Kolokathis A, Campbell M, Cassell GH, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998;17:865-71.
39. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999;18:98-104.
40. Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Pneumococcal vaccine for children. Paediatr Child Health 2002;7:417-8.
41. Jadavji T, Law B, Lebel MH, Kennedy WA, Gold R, Wang EEL. A practical guide for the diagnosis and treatment of pediatric pneumonia. CMAJ 1997;156:S703-11.
42. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;33:1618-24.